Mechanical cues regulate neuronal function and reactivity of glial cells, the origin of gliomas. In this issue of Neuron, Chen et al. (2018) uncover a feedforward loop mediated by the mechanosensitive ion channel Piezo1 and tissue stiffness that drives glioma aggression.
Neuronal development and axonal guidance depend not only on chemical signals but also on mechanical cues from the extracellular matrix (ECM). The idea that mechanics may regulate neuronal function came from early studies showing that sensory cells, involved in touch and hearing, required pressure-sensitive ion channels. Consistently, mechanical perturbations in the ECM surrounding neurons can lead to alterations in axon growth patterns and directionality (Koser et al., 2016) . The biomechanical properties of a tissue in terms of stiffness vary markedly between organs and tissues. The soft neural tissue provides an ideal environment for maturation of neurons and restricts reactivity of glial cells (Pogoda and Janmey, 2018) .
Altered tissue tension and aberrant mechanical signaling are characteristic features of a number of solid tumors, including brain tumors (Barnes et al., 2017) . Malignant glioma is the most common primary brain tumor, two-thirds of which constitutes the lethal grade IV tumor glioblastoma (GBM). Transcriptional profiling has enabled subgrouping of gliomas along a proneural-mesenchymal spectrum. Encapsulated within the skull, gliomas develop in a mechanically challenged environment in which fluid accumulation and high interstitial fluid pressure compresses the tumor and the surrounding normal tissue, driving GBM aggression (Ilkhanizadeh et al., 2018) . The significance of mechanical irregularities was recently highlighted in gliomas in which progression from low-grade to high-grade gliomas, and less aggressive proneural to more aggressive mesenchymal GBMs, was accompanied by enhanced deposition of ECM components such as tenascin C, as well as an overall increase in tissue stiffness (Barnes et al., 2018; Miroshnikova et al., 2016) . ''Mechanical reciprocity,'' used to describe the dynamic interaction between cells and their microenvironment, is mediated by mechanosensing proteins and is critical in maintaining cellular homeostasis. Key mechanosensors include transmembrane integrins, which sense changes in the ECM and convey these signals to mechanotransducers such as focal adhesion kinase (FAK), which, in turn, relays this information to the nucleus via other mechanotransducers paxillin and the transcriptional coactivator with PDZ-binding motif (TAZ), resulting in mechanically activated chromatin remodeling and transcriptional changes. Ion channels represent another important class of mechanoreceptors that convert mechanical stimuli to electrical and chemical signals in cells. Coste et al. (2010) identified mechanically activated cationic ion channels in neuroblastoma cells: Piezo1 and Piezo2 from the Greek word ''píesi,'' meaning ''pressure.'' Electrophysiological studies suggested that Piezo channels are regulated directly by changes in membrane tension. In neurons, blocking Piezo1 drastically reduces axon elongation and pathfinding (Koser et al., 2016) . Although Piezo1 was implicated in promoting tumor aggression in bladder, gastric, and breast cancers, its mechanosensing role and ability to facilitate tumor-ECM interactions remained unclear.
In this issue of Neuron, Chen et al. (2018) employed a comprehensive approach spanning from Drosophila to humans to gain mechanistic insights into Piezo1's ability in promoting GBM aggression. Genetic alterations in growth factor signaling pathways, present in 90% of human GBMs, were used to establish Drosophila glioma models. Development of Drosophila tumors was accompanied by increased deposition of the ECM protein collagen IV, FAK activation, and tissue stiffness compared with non-transformed brain, consistent with findings in human glioma (Miroshnikova et al., 2016) . Knockdown of dPiezo (Drosophila Piezo) reduced tissue stiffness and tumor volume in Drosophila models. Notably, overexpression of components in the integrin pathway, such as integrin-linked kinase and paxillin, as well as ECM components, such as laminin, restored tumor growth in dPiezo-deficient gliomas, suggesting mechanoreciprocity between dPiezo and the integrin machinery in driving tumor progression (Figure 1) . Chen et al. (2018) then extrapolate their findings to human glioma, showing that Piezo1 correlates negatively with survival in glioma patients. Emerging data show that tissue mechanics is dependent on isocitrate dehydrogenase (IDH) mutation status in glioma (Miroshnikova et al., 2016) , present in one-third of all adult gliomas. Chen et al. (2018) found a Piezo1 transcriptional signature that was markedly reduced in gliomas with IDH mutations, which are known to express a hypermethylated phenotype. This raises the question of whether the Piezo1 promoter is epigenetically repressed in IDH mutant tumors. A stiffer ECM was recently reported for recurrent versus primary gliomas (Miroshnikova et al., 2016) . Although Chen et al. (2018) demonstrated Piezo1 expression in primary and recurrent gliomas, it remains unclear whether Piezo1 was differentially expressed and whether expression correlated with tissue stiffness in human tumors. Although they elegantly translate their findings from Drosophila to humans, the fly model has its limitations. Patient-derived xenografts, immuno-competent mouse models, and mice displaying transgenic expression of Piezo1/2 (Ranade et al., 2014) represent useful tools to continue addressing the biological roles of Piezo1, its interactions with the tumor microenvironment, and whether Piezo2 plays a unique role in glioma aggression. This study will also set the stage for investigating the role of Piezo1/2 in other types of brain tumors.
Furthermore, Chen et al. (2018) found that Piezo1 activity was mainly confined to focal adhesion sites in GBM cells. Piezo1 knockdown ablated ion currents and clonogenic growth in response to mechanical force in patient-derived GBM cultures and reduced tumor growth in GBM xenografts. Interestingly, Piezo1 knockdown also resulted in defective focal adhesion assembly and activation of the integrin-FAK pathway, providing a mechanistic explanation for its anti-tumor activity (Figure 1 ). Importantly, Piezo2 had no apparent role and upregulation of Piezo1 in various aggressive cancers made Chen et al. (2018) question whether Piezo1-mediated mechanosensation represents a more general mechanism employed by solid cancers. In line with earlier reports, Chen et al. (2018) found that increased proliferative activity of GBM cells grown on stiffer substrates was dependent on Piezo1 expression. Further studies are needed to address the identity of integrin subunits and the composition of ECM required for Piezo1's function in glioma.
Mesenchymal gliomas display increased treatment resistance and invasiveness. TAZ, a driver of the mesenchymal phenotype in glioma (Bhat et al., 2011) , was identified by Chen et al. (2018) as a Piezo target gene. Since the study was restricted to mesenchymal GBMs, it remains unclear whether a Piezo1-TAZ axis exists and promotes a mesenchymal phenotype. Ionizing radiation, an integral part of standard of care, increases ECM stiffness and induces a mesenchymallike phenotype in tumors, raising the question whether Piezo1 represents a viable therapeutic target to prevent development of treatment-resistant and invasive gliomas. In highly heterogeneous gliomas, it remains unclear whether Piezo channels are expressed on treatment-resistant (e.g., cancer stem cells) tumor cells. It is believed that mechanical forces are elevated in the tumor core and markedly reduced at the periphery. It is therefore plausible that the tumor core experiencing increased tissue stiffness and hypoxic conditions is more resistant to therapy. It will be important to address whether Piezo1 expression is uniform or dynamically regulated by tissue stiffness in heterogeneous tumors. GsMTx-4 is a gating modifier peptide from spider venom and is a blocker of mechanosensitive ion channels, including Piezo1. Additional structural information of Piezo channels will facilitate development of specific inhibitors. Immunotherapies targeting epitopes of Piezo1 or Piezo1-driven expression of proteins/gangliosides represent alternative therapeutic approaches to target solid cancers.
Brain development, function, and homeostasis rely on the ability of cells and tissues to successfully sense and respond to mechanical cues within their microenvironment. Perturbations in mechanical signaling are implicated in developmental defects as well as several neurological pathologies, including Alzheimer's and Parkinson's diseases (Barnes et al., 2017) . Given the prevalent crosstalk between mechanosensitive ion channels and the integrin machinery in disease progression, it is plausible that Piezo1 plays a mechanosensing role in neurological disorders, in particular conditions associated with glial scar formation. Chen et al. (2018) have paved the way for future studies investigating Piezo1-mediated mechanotransduction in nervous system pathologies and solid cancers.
